Bora Pharmaceuticals CoTPE:6472 -1.05%87 Days Inventory is 97.95 as of Dec. 2025, which is 2% below its 10-year median of 100.19. GuruFocus rates TPE:6472 with a GF Score™ of 87/100 and a GF Value™ of NT$718.20 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 919 Drug Manufacturers companies, Bora Pharmaceuticals Co ranks better than 66.38% on this metric.
The historical rank and industry rank for Bora Pharmaceuticals Co's Days Inventory or its related term are showing as below:
TPE:6472'
s Days Inventory Range Over the Past 10 Years
Min: 48.89 Med: 100.19 Max: 228.21
Current: 127.28
During the past 13 years, Bora Pharmaceuticals Co's highest Days Inventory was 228.21. The lowest was 48.89. And the median was 100.19.
TPE:6472's Days Inventory is ranked better than 66.38% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs TPE:6472: 127.28
Bora Pharmaceuticals Co's Days Inventory
declined
from Dec. 2024 (158.71) to Dec. 2025 (97.95).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bora Pharmaceuticals Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.93.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bora Pharmaceuticals Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.68.
Bora Pharmaceuticals Co (TPE:6472) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bora Pharmaceuticals Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bora Pharmaceuticals Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bora Pharmaceuticals Co Days Inventory Related Terms
Bora Pharmaceuticals Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bora Pharmaceuticals Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bora Pharmaceuticals Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bora Pharmaceuticals Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bora Pharmaceuticals Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bora Pharmaceuticals Co (TPE:6472) has a Days Inventory of 97.95 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bora Pharmaceuticals Co and its competitors. This is near median its historical median of 100.19. Over the past decade, Bora Pharmaceuticals Co's Days Inventory has ranged from 48.89 to 228.21. According to the industry distribution chart, Bora Pharmaceuticals Co ranks #309 out of 919 companies in the Drug Manufacturers industry, placing it in the top 33.6%.
Is Bora Pharmaceuticals Co's Days Inventory too high?
Bora Pharmaceuticals Co's current Days Inventory of 97.95 is near median its 10-year median of 100.19. Over the past 10 years, this metric has ranged from a low of 48.89 to a high of 228.21. The Drug Manufacturers industry median Days Inventory is 164.48. Bora Pharmaceuticals Co's value of 97.95 is 40.4% below this industry median. Based on the distribution chart, Bora Pharmaceuticals Co ranks #309 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Bora Pharmaceuticals Co has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bora Pharmaceuticals Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Bora Pharmaceuticals Co ranks #309 out of 919 companies for Days Inventory. This puts Bora Pharmaceuticals Co in the upper half of its industry. The industry median Days Inventory is 164.48. Bora Pharmaceuticals Co's value of 97.95 is 40.4% below this benchmark. Historically, Bora Pharmaceuticals Co's own Days Inventory has ranged from 48.89 to 228.21 over the past decade. While the company's 10-year median is 100.19 vs. the industry median of 164.48, Bora Pharmaceuticals Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bora Pharmaceuticals Co's current Days Inventory of 97.95 is 40.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bora Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bora Pharmaceuticals Co's current Days Inventory is 97.95, which is near median its own 10-year median of 100.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bora Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Bora Pharmaceuticals Co (TPE:6472) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$718.20, compared to a current price of NT$425.50 — trading 40.8% below its estimated fair value. The current Days Inventory is 97.95, which is near median its 10-year median of 100.19 and 40.4% below the Drug Manufacturers industry median of 164.48. Bora Pharmaceuticals Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bora Pharmaceuticals Co (TPE:6472), the current Days Inventory is 97.95 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bora Pharmaceuticals Co (TPE:6472) Overvalued in 2026?
Based on GuruFocus' analysis, Bora Pharmaceuticals Co stock appears to be undervalued.
The current stock price of NT$425.50 is trading 40.8% below its estimated GF Value™ of NT$718.20.
GuruFocus considers Bora Pharmaceuticals Co to be Significantly Undervalued.
Key valuation signals for TPE:6472:
Days Inventory: 97.95 (near median its 10-year median of 100.19)
GF Value™: NT$718.20 vs. price of NT$425.50 (40.8% below fair value)
Industry Position: 40.4% below the Drug Manufacturers median (#309 of 919)
No single metric tells the full story. See the TPE:6472 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Sales segment: sale of pharmaceuticals, generics, and healthcare products. CDMO segment: contract development and manufacturing organization of pharmaceuticals. Other segment: Others. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.
87GF Score
Get the complete analysis for TPE:6472
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6472 has been successfully added to your 
